Navigation Links
SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
Date:6/5/2008

Company Achieves Important Milestone in Development of Next Generation

Cardiovascular Drug

CALGARY, June 5 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company dedicated to developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it has demonstrated that its safflower-produced Apo AI(Milano) (safflower Apo AI(Milano)) is functional in a widely accepted animal model. Working with the laboratory of Dr. Jean Claude Tardif at the Montreal Heart Institute (MHI), the company demonstrated that safflower Apo AI(Milano) increased cholesterol mobilization substantially in mice which, in conjunction with analytical and in vitro assays, indicates that safflower Apo AI(Milano) is physiologically and pharmaceutically comparable to microbially-produced Apo AI. In human trials, microbially-produced Apo AI(Milano) has been demonstrated to remove plaque from arteries (plaque regression), and holds potential for addressing one of the greatest unmet medical needs today - the reversal of atherosclerosis.

Dr. Maurice Moloney, founder and chief scientific officer of SemBioSys commented, "Scientists at SemBioSys and our academic collaborators have conducted extensive work on safflower Apo AI(Milano) and have established that safflower Apo AI(Milano) is comparable to Apo AI derived from other sources, as described in the literature. Its identity and functionality was confirmed through use of mass spectrometry, and lipid clearance, cellular cholesterol efflux and whole-animal cholesterol mobilization assays."

Dr. Jean-Claude Tardif, director of the Montreal Heart Institute Research Centre, who is a world leader in the study of HDLs and the physiological role of Apo AI noted, "Apo AI and Apo AI(Milano) hold the potential to be a useful therapy for the treatment of cardiovascular disease through the unique mechanism of plaque regression. Our research at
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
2. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
3. SemBioSys announces first quarter 2008 financial and operational results
4. SemBioSys receives milestone payments from AVAC Ltd.
5. SemBioSys initiates toxicology study for safflower-produced insulin
6. SemBioSys announces 2007 financial and operational results
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
9. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
10. SemBioSys signs option agreement for safflower-produced food ingredient
11. SemBioSys announces 2007 third quarter results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up ... many of them wrote: "Take better care of my furry companion." ... designer clothes and top-brand carrying cases to take the little canine ... might also feel compelled to buy some pricey toys at the ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management ... Product Strategy. In this role, Michelle will work with current ... in the development of iLab products. Her main goal will ... to the scientific community by offering the most advanced, user-friendly, ...
(Date:1/14/2014)... Kinaxis ®, provider of RapidResponse ®, a cloud-based supply ... ( S&OP ) service, is proud to be a gold ... held at the Hilton San Diego Bayfront, January 30 – ... Kaszas , Director of Supply Chain at Amgen, as she ...
(Date:1/14/2014)... 14, 2014 Independent publisher Bitingduck Press, ... Montreal, Canada, has big ideas for 2014 in production ... goals are to produce high-quality, low-cost, DRM-free ebooks and ... businesses. , The first major development will be ...
Breaking Biology Technology:New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... June 8 CSL Limited (ASX: CSL) and Talecris Biotherapeutics, ... their merger agreement, announced on August 12, 2008, under which ... , , Dr. Brian McNamee, CEO and Managing Director ... Federal Trade Commission (FTC) resolved to block the transaction. ...
... Calif., June 8 Proteolix, Inc. today announced data from ... for the treatment of multiple myeloma at the 14th Congress ... Carfilzomib is the first in a new class of selective, ... of hematologic malignancies and solid tumors. , ...
... 8 /PRNewswire/ -- Pasteuria Bioscience announced that ... Agency (EPA) for Pasteuria usgae . This is ... spp., a natural bacteria prevalent in soil that have ... nematodes. , , "We,re very pleased to ...
Cached Biology Technology:CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 2CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 2Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 4Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 5Pasteuria Bioscience Receives EPA Registration for Nematode Control 2
(Date:4/23/2014)... Like a hungry diner ripping open a dinner roll, ... must tear open a hydrogen molecule. Now researchers have ... the two halves of its hydrogen feast. The view ... make the catalyst work better for alternative energy uses. ... shown precisely where the hydrogen halves end up in ...
(Date:4/23/2014)... 23 2014) A team of researchers ... (hNSCs) into the brains of nonhuman primates and ... 24 months found that the hNSCs had differentiated ... cause tumors. , The study will be published ... but is currently freely available on-line as ...
(Date:4/23/2014)... have found evidence of an interaction between prenatal ... behavior in children, especially in girls. , "The ... to prenatal smoking will have behavioral problems. ... Boutwell, Assistant Professor at Sam Houston State University, ... the study. "One possible explanation for this ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
... head. What do you do? You probably first move out of ... object is. Your brain is able to quickly switch from detecting ... is through a phenomenon called adaptation. A new study in ... Neuroscience details the biological basis of this ability for rapid ...
... , WASHINGTON, D.C., November 21, 2010 -- Jump ropes are ... But what about the underlying physics? How do jump ropes ... Aristoff and Howard Stone of Princeton University have built themselves ... parameters -- rope rotation rate, rope density, diameter, length, and ...
... The Innovative Vector Control Consortium (IVCC) has received $50 ... continue its work to develop new insecticides for the ... malaria, dengue and other neglected tropical diseases. ... grant of $50.7 million over five years from the ...
Cached Biology News:Study reveals neural basis of rapid brain adaptation 2Study reveals neural basis of rapid brain adaptation 3
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
Biology Products: